NCT00318760View on ClinicalTrials.gov

Effect of Clonidine on Responses to Imagery Scripts

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

June 14, 2005

Study Completion Date

August 7, 2013

Conditions
Cocaine AbuseHeroin Abuse
Interventions
DRUG

Clonidine

0.1 or 0.2 mg oral, one dose

DRUG

Placebo

oral capsule 1 dose

Trial Locations (1)

21224

National Institute on Drug Abuse, Baltimore

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00318760 - Effect of Clonidine on Responses to Imagery Scripts | Biotech Hunter | Biotech Hunter